APH vs. SPI, ESP, RTN, IPF, SGM, MCP, MSI, BERI, AMAT, and STM
Should you be buying Alliance Pharma stock or one of its competitors? The main competitors of Alliance Pharma include Spire Healthcare Group (SPI), Empiric Student Property (ESP), The Restaurant Group (RTN), International Personal Finance (IPF), Sigma Capital Group (SGM), Martin Currie Asia Unconstrand Trust (MCP), MS INTERNATIONAL (MSI), BlackRock Energy and Resources (BERI), Amati AIM VCT (AMAT), and STM Group (STM). These companies are all part of the "electronic equipment" industry.
Alliance Pharma vs.
Alliance Pharma (LON:APH) and Spire Healthcare Group (LON:SPI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, profitability, dividends, analyst recommendations, institutional ownership, valuation, risk, earnings and media sentiment.
Spire Healthcare Group has a net margin of 1.96% compared to Alliance Pharma's net margin of -18.34%. Spire Healthcare Group's return on equity of 3.82% beat Alliance Pharma's return on equity.
In the previous week, Alliance Pharma had 1 more articles in the media than Spire Healthcare Group. MarketBeat recorded 1 mentions for Alliance Pharma and 0 mentions for Spire Healthcare Group. Spire Healthcare Group's average media sentiment score of 0.00 beat Alliance Pharma's score of -0.88 indicating that Spire Healthcare Group is being referred to more favorably in the news media.
Alliance Pharma has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Spire Healthcare Group has a beta of 0.96, meaning that its stock price is 4% less volatile than the S&P 500.
Spire Healthcare Group has higher revenue and earnings than Alliance Pharma. Alliance Pharma is trading at a lower price-to-earnings ratio than Spire Healthcare Group, indicating that it is currently the more affordable of the two stocks.
Alliance Pharma presently has a consensus price target of GBX 6,250, suggesting a potential upside of 9,635.20%. Spire Healthcare Group has a consensus price target of GBX 314.67, suggesting a potential upside of 70.20%. Given Alliance Pharma's higher probable upside, equities research analysts plainly believe Alliance Pharma is more favorable than Spire Healthcare Group.
Spire Healthcare Group received 153 more outperform votes than Alliance Pharma when rated by MarketBeat users. However, 61.89% of users gave Alliance Pharma an outperform vote while only 60.96% of users gave Spire Healthcare Group an outperform vote.
66.3% of Alliance Pharma shares are held by institutional investors. Comparatively, 50.4% of Spire Healthcare Group shares are held by institutional investors. 12.0% of Alliance Pharma shares are held by insiders. Comparatively, 34.7% of Spire Healthcare Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Alliance Pharma pays an annual dividend of GBX 2 per share and has a dividend yield of 3.1%. Spire Healthcare Group pays an annual dividend of GBX 3 per share and has a dividend yield of 1.6%. Alliance Pharma pays out -32.2% of its earnings in the form of a dividend. Spire Healthcare Group pays out 42.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Alliance Pharma is clearly the better dividend stock, given its higher yield and lower payout ratio.
Summary
Spire Healthcare Group beats Alliance Pharma on 12 of the 20 factors compared between the two stocks.
Get Alliance Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alliance Pharma Competitors List
Related Companies and Tools
This page (LON:APH) was last updated on 4/18/2025 by MarketBeat.com Staff
Buy APH Stock Free APH Stock Alerts